Abstract: Abstract AMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS The present invention relates to compounds of formula (I), including their stereoisomers and pharmaceutically acceptable salts. This invention also relates to methods of making such compounds and pharmaceutical compositions comprising such compounds. The compounds of this invention are useful in the treatment of various disorders that are related to 5-hydroxytryptamine 4 (5-HT4) receptor.
Please see attached in pdf
| # | Name | Date |
|---|---|---|
| 1 | General Power of Authority.pdf ONLINE | 2015-02-13 |
| 2 | Form 5.pdf ONLINE | 2015-02-13 |
| 3 | Form 3.pdf ONLINE | 2015-02-13 |
| 4 | Drawings.pdf ONLINE | 2015-02-13 |
| 5 | Complete Specification.pdf ONLINE | 2015-02-13 |
| 6 | Abstract.pdf ONLINE | 2015-02-13 |
| 7 | 709-CHE-2015 FORM-1 09-03-2015.pdf | 2015-03-09 |
| 8 | 709-CHE-2015 CORRESPONDENCE OTHERS 09-03-2015.pdf | 2015-03-09 |
| 9 | General Power of Authority.pdf | 2015-03-13 |
| 10 | Form 5.pdf | 2015-03-13 |
| 11 | Form 3.pdf | 2015-03-13 |
| 12 | Drawings.pdf | 2015-03-13 |
| 13 | Complete Specification.pdf | 2015-03-13 |
| 14 | Abstract.pdf | 2015-03-13 |
| 15 | 709-CHE-2015 POWER OF ATTORNEY 18-03-2015.pdf | 2015-03-18 |
| 16 | 709-CHE-2015 CORRESPONDENCE OTHERS 18-03-2015.pdf | 2015-03-18 |
| 17 | Other Document [23-03-2016(online)].pdf | 2016-03-23 |
| 18 | Marked Copy [23-03-2016(online)].pdf | 2016-03-23 |
| 19 | Form 13 [23-03-2016(online)].pdf | 2016-03-23 |
| 20 | Description(Complete) [23-03-2016(online)].pdf | 2016-03-23 |
| 21 | 709-CHE-2015-Form 5-261115.pdf | 2016-05-30 |
| 22 | 709-CHE-2015-Form 13-261115.pdf | 2016-05-30 |
| 23 | 709-CHE-2015-Form 1-261115.pdf | 2016-05-30 |
| 24 | 709-CHE-2015-Correspondence-F1-F5-Affidavit-261115.pdf | 2016-05-30 |
| 25 | 709-CHE-2015-Affidavit-261115.pdf | 2016-05-30 |
| 26 | 709-CHE-2015-OTHERS-040416.pdf | 2016-06-14 |
| 27 | 709-CHE-2015-Correspondence-Form 3-040416.pdf | 2016-06-14 |
| 28 | 709-CHE-2015-FORM 18 [29-01-2019(online)].pdf | 2019-01-29 |
| 29 | 709-CHE-2015-FER.pdf | 2019-12-27 |
| 30 | 709-CHE-2015-OTHERS [09-06-2020(online)].pdf | 2020-06-09 |
| 31 | 709-CHE-2015-FORM 3 [09-06-2020(online)].pdf | 2020-06-09 |
| 32 | 709-CHE-2015-FER_SER_REPLY [09-06-2020(online)].pdf | 2020-06-09 |
| 33 | 709-CHE-2015-DRAWING [09-06-2020(online)].pdf | 2020-06-09 |
| 34 | 709-CHE-2015-CORRESPONDENCE [09-06-2020(online)].pdf | 2020-06-09 |
| 35 | 709-CHE-2015-COMPLETE SPECIFICATION [09-06-2020(online)].pdf | 2020-06-09 |
| 36 | 709-CHE-2015-CLAIMS [09-06-2020(online)].pdf | 2020-06-09 |
| 37 | 709-CHE-2015-ABSTRACT [09-06-2020(online)].pdf | 2020-06-09 |
| 38 | 709-CHE-2015-RELEVANT DOCUMENTS [10-06-2020(online)].pdf | 2020-06-10 |
| 39 | 709-CHE-2015-PETITION UNDER RULE 137 [10-06-2020(online)].pdf | 2020-06-10 |
| 40 | 709-CHE-2015-FORM-26 [10-06-2020(online)].pdf | 2020-06-10 |
| 41 | 709-CHE-2015-US(14)-HearingNotice-(HearingDate-14-08-2020).pdf | 2020-07-13 |
| 42 | 709-CHE-2015-REQUEST FOR ADJOURNMENT OF HEARING UNDER RULE 129A [10-08-2020(online)].pdf | 2020-08-10 |
| 43 | 709-CHE-2015-US(14)-ExtendedHearingNotice-(HearingDate-15-09-2020).pdf | 2020-08-13 |
| 44 | 709-CHE-2015-REQUEST FOR ADJOURNMENT OF HEARING UNDER RULE 129A [11-09-2020(online)].pdf | 2020-09-11 |
| 45 | 709-CHE-2015-Correspondence to notify the Controller [13-10-2020(online)].pdf | 2020-10-13 |
| 46 | 709-CHE-2015-Written submissions and relevant documents [27-10-2020(online)].pdf | 2020-10-27 |
| 47 | 709-CHE-2015-Annexure [27-10-2020(online)].pdf | 2020-10-27 |
| 48 | 709-CHE-2015-Correspondence_05-11-2020.pdf | 2020-11-05 |
| 49 | 709-CHE-2015-Affida vit_05-11-2020.pdf | 2020-11-05 |
| 50 | 709-CHE-2015-PatentCertificate31-12-2020.pdf | 2020-12-31 |
| 51 | 709-CHE-2015-IntimationOfGrant31-12-2020.pdf | 2020-12-31 |
| 52 | 709-CHE-2015-US(14)-ExtendedHearingNotice-(HearingDate-14-10-2020).pdf | 2021-10-17 |
| 1 | WIPO-709CHE2015_23-12-2019.pdf |
| 2 | PSearch709CHE2015_23-12-2019.pdf |